SOURCE: Antisoma plc

June 18, 2009 07:06 ET

Antisoma to present at Piper Jaffray Europe Conference in London

LONDON, UK--(Marketwire - June 18, 2009) -

18 June 2009, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive, Glyn Edwards, will present an overview of the Company's strategy, programmes and prospects on Wednesday June 24th at 13.30 BST (08:30 EDT) at the Piper Jaffray Fourth Annual Europe Conference being held in London.

A webcast of the presentation will be available on Antisoma's website at

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Daniel Elger
VP, Marketing & Communications
Antisoma plc
+44 7909 915 068

Background on Antisoma

Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit for further information about Antisoma.



This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2009. All rights reserved.

Contact Information